atopic dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Meets the diagnostic criteria for atopic dermatitis as described above, confirmed as mild to moderate AD (SCORAD score 0–50) (2)Aged 18–65 years, no gender restrictions (3)Willing to undergo and comply with topical medication wet dressings (4)Voluntary participants will sign a written informed consent form
Exclusion criteria
Exclusion criteria: (1) Patients with severe AD (SCORAD score > 50); (2) Allergic to the test drug or any of its components; (3) Patients in the lactation period, pregnancy, suspected pregnancy, or planning to become pregnant during the treatment period; (4) Patients with immunodeficiency or autoimmune diseases, or those with underlying diseases (such as diabetes), which may have a potential impact on the efficacy and prognosis of this study; (5) Lesion sites on the skin of the subjects have wounds, abrasions, tattoos, or other conditions that may affect the determination of test results; (6) Those who cannot actively cooperate, have poor compliance, incomplete data collection, or participate in other clinical trials during the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scoring Atopic Dermatitis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical dermatologist evaluation form;The Dermatology Life Quality Index (DLQI) assessment form; | — |
Countries
China
Contacts
Hospital Affiliated to Chengdu University of TCM